Press release
Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Exclusive Trends Analysis with Forecast to 2034
According to the latest market research report by InsightAce Analytic, the Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 230.8 Million in 2024 and is predicted to reach 1,456.9 Million by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034
Request For Free Sample Pages :
https://www.insightaceanalytic.com/request-sample/1152
In recent years, the field of microbiome research has experienced remarkable growth, positioning itself as a pivotal area in the development of next-generation medical treatments. While the impact of the microbiome on human health is well-established, ongoing research has broadened its potential across a variety of therapeutic and clinical applications.
Comprising a vast and diverse array of microorganisms residing within the human body, the microbiome exerts a significant influence on numerous physiological processes. Emerging scientific data highlights the potential of engineered live biotherapeutics-genetically modified microorganisms-to precisely target disease mechanisms, further reinforcing the critical role of microbial interactions in the management and prevention of chronic and complex conditions.
The prominent players in the Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing industry include:
Quay Pharmaceuticals, Cobra Biologics Limited, Cerbios-Pharma SA, List Biological Labs, Inc., Arranta Bio, BacThera, Luina Bio Pty Ltd, 4D pharma plc, Paras Biopharmaceuticals Finland Oy, Capsugel, Deerland Probiotics & Enzymes, Paragon Bioservices, UAS Labs, Biose, Cobra Biologics, Cerbios, Inpac Probiotics, BJP Laboratories, S-Biomedic, Meteoric Biopharmaceuticals, BiomX, Universal Stabilization Technologies, Assembly Biosciences, Wacker Biotech, Chung Mei Pharmaceutical and Other Prominent Players.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1152
Key Industry Developments from Leading Players:
• In Nov 2021, Bacthera and Seres Therapeutics announced a collaboration to manufacture SER-109, Seres' lead product candidate for recurrent Clostridioides difficile infection (CDI). Under the terms of the agreement, Bacteria is establishing a dedicated facility for commercial manufacturing in its new Microbiome Center of Excellence, a manufacturing site dedicated to the production of s located on Lonza's Ibex campus in Visp, Switzerland. The agreement between Bacteria and Seres Therapeutics aims to expand upon Seres' initial commercial manufacturing supply chain
• In May 2021, Bacthera's drug product facility in Basel, Switzerland, and by the Danish Medicines Agency at Bacthera's drug substance facility in Hørsholm, Denmark, both facilities had been granted manufacturing licenses by the respective national health authorities. The permit will allow the Company to fulfill the scope of bringing innovative Live Biotherapeutic Products (LBP) to patients with unmet medical needs
• In Nov 2019, Arranta Bio has received an US$82 million funding round and a strategic partnership with Thermo Fisher Scientific.Through this partnersship with Thermo Fisher, Arranta has access to the company's a wide range of product portfolio and services and provided materials to Thermo Fisher for use in gene therapy production
• In Oct 2019, 4D pharma plc announced research collaboration and option to license agreement with MSD, the tradename of Merck & Co., Inc. to discover and develop Live Biotherapeutics ("s") for vaccines. Through this agreement, 4D's proprietary MicroRx platform will be paired with MSD's expertise in developing and commercializing novel vaccines to discover and develop s as vaccines in up to three undisclosed indications
• In April 2019, Chr. Hansen Holding A/S and Lonza AG equally shared approximately €90m ($101.5m) to establish a CDMO (contract development and manufacturing organization) for biotherapeutic products. The investment was in two phases, bagan with an update to Lonza's existing facilities in Hørsholm, Denmark, for cGMP production of drug substances (anaerobic bacteria). It also equiped new facilities in Basel, Switzerland, for drug product development and manufacturing.
Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Regional Analysis:
In 2021, North America held the largest share of the global market, driven by substantial research and development (R&D) investments and the rapid adoption of advanced technologies. The region is expected to maintain its leadership position throughout the forecast period, supported by a strong commercial presence in live biotherapeutics and microbiome-based products, as well as the availability of biopharmaceutical contract manufacturers. The Asia-Pacific region is also anticipated to experience significant growth during the forecast period, fueled by increasing investments and advancements in the sector. Similarly, Europe is projected to witness considerable expansion, primarily due to the growing R&D initiatives undertaken by key market players.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1152
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Segments
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2022 to 2030 based on Product Manufactured
• APIs
• FDFs
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 based on Type of Formulation
• Solid Formulations
• Oral Liquids
• Injectables
• Others
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 based on Scale of Operation
• Preclinical Scale Operations
• Clinical Scale Operations
• Commercial Scale Operations
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 based on Company Size
• Small-sized Companies
• Mid-sized Companies
• Large Companies
The Global Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• U.S.
• Canada
Europe Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates Revenue (US$ Million) by Country, 2022 to 2030
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Live Biotherapeutic Products (LBP) And Microbiome Contract Manufacturing Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• South Africa
• GCC Countries
• Rest of the Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Exclusive Trends Analysis with Forecast to 2034 here
News-ID: 4097534 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Prochlorperazine Maleate Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Prochlorperazine Maleate Market- (By Indication (Nausea and Vomiting Management, Vertigo, Mental Health Disorders (e.g., Schizophrenia)), By Dosage Form (Oral Tablets, Rectal Suppositories, Injectable Formulations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research…
Primary Cells Market Survey Detailed Analysis and Forecast 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Primary Cells Market- (By Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Life Science Research Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Primary Cells Market Size is valued at USD…
Predictive Disease Analytics Market expected to Witness Huge Revenue Growth to 2 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Predictive Disease Analytics Market Size, Share & Trends Analysis Report By Component (Hardware, Software & Services), By Deployment (On-premise and Cloud-based), By End-user (Healthcare Providers, Healthcare Payers)- Market Outlook And Industry Analysis 2034"
The Global Predictive Disease Analytics Market is estimated to reach over USD 22.6 Bn by 2034, exhibiting a CAGR of 21.2% during…
Predictive Biomarkers Market Current Scenario with Future Trends Analysis to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Predictive Biomarkers Market- (By Indication (Cancer, Neurological Disorder, Cardiovascular Disorder, Immunological Disorder, Others), By End-Use (Diagnostic Centers, Contract Research Organizations (CROs), Academic Research Institutes, Pharma & Biotech Companies, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Predictive Biomarkers Market is expected to grow with…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
